Profile | GDS4284 / AFFX-HUMRGE/M10098_3_at |
Title | Chronic lymphocytic leukemia response to antisense Bcl-2 inhibitor SPC2996: peripheral blood |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM687644 | Patient 401 control | 1170.33 | 76 |
GSM687648 | Patient 402 control | 571.02 | 66 |
GSM687653 | Patient 403 control | 751.065 | 70 |
GSM687658 | Patient 404 control | 224.065 | 50 |
GSM687663 | Patient 411 control | 595.865 | 66 |
GSM687668 | Patient 422 control | 528.486 | 65 |
GSM687673 | Patient 424 control | 905.606 | 72 |
GSM687678 | Patient 425 control | 354.158 | 57 |
GSM687683 | Patient 427 control | 683.832 | 67 |
GSM687688 | Patient 428 control | 685.027 | 68 |
GSM687695 | Patient 441 control | 1041.51 | 76 |
GSM687699 | Patient 443 control | 175.827 | 42 |
GSM687704 | Patient 444 control | 334.802 | 57 |
GSM687707 | Patient 448 control | 1527.16 | 81 |
GSM687712 | Patient 449 control | 321.634 | 56 |
GSM687719 | Patient 450 control | 229.636 | 48 |
GSM687724 | Patient 451 control | 1287.61 | 78 |
GSM687728 | Patient 452 control | 931.528 | 74 |
GSM687646 | Patient 401 treated 24h | 874.697 | 72 |
GSM687649 | Patient 402 treated 24h | 324.298 | 57 |
GSM687665 | Patient 411 treated 24h | 608.391 | 66 |
GSM687651 | Patient 402 treated 4 weeks | 693.609 | 68 |
GSM687667 | Patient 411 treated 4 weeks | 516.835 | 64 |
GSM687670 | Patient 422 treated 24h | 600.413 | 66 |
GSM687671 | Patient 422 treated 4 weeks | 512.438 | 64 |
GSM687654 | Patient 403 treated 24h | 628.668 | 67 |
GSM687675 | Patient 424 treated 24h | 835.459 | 71 |
GSM687685 | Patient 427 treated 24h | 504.499 | 63 |
GSM687656 | Patient 403 treated 4 weeks | 1330.02 | 78 |
GSM687677 | Patient 424 treated 4 weeks | 731.936 | 69 |
GSM687687 | Patient 427 treated 4 weeks | 561.532 | 65 |
GSM687692 | Patient 428 treated 4h | 414.012 | 61 |
GSM687716 | Patient 449 treated 4h | 366.175 | 59 |
GSM687722 | Patient 450 treated 4h | 467.751 | 61 |
GSM687680 | Patient 425 treated 24h | 344.065 | 58 |
GSM687690 | Patient 428 treated 24h | 346.908 | 59 |
GSM687700 | Patient 443 treated 24h | 492.213 | 60 |
GSM687705 | Patient 444 treated 24h | 380.988 | 60 |
GSM687714 | Patient 449 treated 24h | 309.27 | 57 |
GSM687721 | Patient 450 treated 24h | 178.839 | 42 |
GSM687682 | Patient 425 treated 4 weeks | 405.743 | 61 |
GSM687694 | Patient 428 treated 4 weeks | 179.859 | 48 |
GSM687702 | Patient 443 treated 4 weeks | 228.425 | 48 |
GSM687718 | Patient 449 treated 4 weeks | 503.624 | 64 |
GSM687723 | Patient 450 treated 4 weeks | 200.091 | 47 |
GSM687661 | Patient 404 treated 4h | 283.615 | 54 |
GSM687710 | Patient 448 treated 4h | 952.185 | 74 |
GSM687726 | Patient 451 treated 4h | 1111.06 | 76 |
GSM687730 | Patient 452 treated 4h | 27395.6 | 99 |
GSM687660 | Patient 404 treated 24h | 441.727 | 62 |
GSM687697 | Patient 441 treated 24h | 1064.08 | 76 |
GSM687709 | Patient 448 treated 24h | 970.266 | 74 |
GSM687725 | Patient 451 treated 24h | 1004.89 | 74 |
GSM687729 | Patient 452 treated 24h | 1121.47 | 78 |
GSM687727 | Patient 451 treated 4 weeks | 1064.33 | 75 |
GSM687731 | Patient 452 treated 4 weeks | 869.694 | 72 |